Target intelligence / Profile preview

Visceral smooth muscle (VSM)

Target
VSM
Molecular classification
Other
01

Overview

Visceral smooth muscle, also known as single-unit smooth muscle, is a type of non-striated muscle found in the walls of hollow internal organs such as the stomach, intestines, bladder, and uterus (StatPearls, 2023, NBK526125). Unlike multi-unit smooth muscle, the cells in visceral smooth muscle are connected by gap junctions, allowing them to contract as a single coordinated unit or functional syncytium (Britannica, 2024). Its primary biological function is to facilitate involuntary movements like peristalsis and the regulation of organ volume through sustained, rhythmic contractions (NIH, 2022). In clinical pharmacology, this tissue is not a single molecular target but rather a physiological site containing various receptors, such as muscarinic and adrenergic receptors, and ion channels like L-type calcium channels (PubMed, 2021, PMC8143845). Drugs targeting these components are used to treat conditions like overactive bladder, irritable bowel syndrome, and asthma. Because these receptors are often expressed across multiple organ systems, therapeutic intervention can lead to systemic safety concerns such as hypotension, dry mouth, or gastrointestinal distress.

Other names
Unitary smooth muscleSingle-unit smooth muscleInvoluntary muscle
02

Mechanism of action

Pharmacological agents typically modulate visceral smooth muscle tone by acting as agonists or antagonists on G protein-coupled receptors (such as muscarinic M3 or adrenergic beta-2 receptors) or by blocking voltage-gated calcium channels to influence intracellular calcium concentrations and subsequent cross-bridge cycling.

03

Biological functions

ContractionPeristalsisRegulation of organ volumeInvoluntary movement
04

Disease associations

Irritable bowel syndromeOveractive bladderAsthmaAchalasiaUterine fibroidsGastroparesis
05

Safety considerations

Systemic side effects due to lack of organ specificityHypotensionGastrointestinal motility issuesUrinary retentionTachycardia
06

Interacting drugs

Atropine

5 more in the full profile.

07

Biomarkers

Alpha-smooth muscle actin (α-SMA)Calponin-1Smooth muscle myosin heavy chain (SM-MHC)Desmin

Beyond the preview

Go deeper on Visceral smooth muscle (VSM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visceral smooth muscle (VSM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call